In this post, oncology pharmacist Cynthia Herrera discusses how people with cancer can work with their oncology pharmacist to receive support and what role the oncology pharmacist plays on the cancer care team.
In this article from The ASCO Post, Dr. Mark Lewis describes how his inherited cancer diagnosis has impacted his career as an oncologist and how it’s made him better able to empathize with his patients.
In this Your Stories podcast from Conquer Cancer, the ASCO Foundation, breast cancer survivor Kimberly Irvine discusses talking with her children about her diagnosis and how her family used the experience as an opportunity for empowerment.
In this post, Dr. Matthew Schabath discusses the unique challenges LGBTQ people with cancer face throughout their experience, what resources are available to help, and how the health care community is working to eliminate disparities in care.
In this post, Dr. Abenaa Brewster discusses why attending your scheduled cancer care and screening appointments during the COVID-19 pandemic is so important and how to do so safely.
In this post, Dr. Carolyn Hendricks discusses the benefits of the new shift to televisits, and how people with cancer can make the most out of their time with their doctor during these appointments.
Dr. Fidel Rubagumya describes what treating people with cancer is like in Rwanda, including some of the longstanding challenges and recent achievements in caring for and supporting patients and survivors in the country.
Dr. Anthony Provenzano discusses how he’s seen COVID-19 impact people with cancer, including the uncertainty and fear the pandemic has caused and how people can cope.
In this post, Dr. Narjust Florez discusses the unique challenges people living with and beyond lung cancer face in terms of their sexual health, and how they can best address their sexual concerns with their health care team.
The 2020 National Cancer Opinion Survey reveals the COVID-19 pandemic’s effects on cancer screening and mental health, racism’s impact on health care, and widely held misperceptions about cancer clinical trials.
